Here are the 25 companies currently standing out to me for their growth potential, market position, or long-term asymmetric upside. $Spotify Technology S.A.(SPOT)$ — Audio streaming platform with more than 600 million active users worldwide. $Coinbase Global, Inc.(COIN)$ — A leading blockchain platform with the balance sheet and management team to benefit if crypto, blockchain and Web3 continue expanding over the next decade. $Portillo’s Inc.(PTLO)$ — A fast-growing restaurant brand built around hot dogs, burgers and a scalable store model. $Virgin Galactic(SPCE)$ — A space tourism company pursuing a new category of comm
Hello everyone! Today i want to share some trading ideas with you! Right... $TransMedics Group, Inc.(TMDX)$ is undervalued at $86. -> CEO says Europe is ~50% of the entire global transplant opportunity (currently only generating ~$20M of revenue in Europe). -> CEO forecasts 30,000 transplants by 2032 generating $2 billion in revenue (18% CAGR for 6 years). -> Director buying $110k worth of shares. -> CEO regularly bought in the +$100 range. -> 2H 2027 is the year revenue starts to get generated from kidneys and Europe. I forecast we hit $2B in revenue in 2032 (18% CAGR from here) which is in line with management commentary if some of the above goes right. At 40% EBITDA margins that's $800M in EBITDA (or 31% CAGR from
Today, the Asymmetric Universe includes 25 stocks I’ve covered in spotlight articles, and the list will continue to grow over time. 🌱 Being part of the universe does not guarantee an investment. Some stocks may never receive capital, while others can be purchased multiple times as opportunities emerge. 💰 How I Allocate New Capital I invest $500 in new capital every month. 📌 If the $S&P 500(.SPX)$ or $NASDAQ 100(NDX)$ falls 20% from its all-time high, monthly capital increases to $1,000. 📌 At a 30% decline, I’ll add $1,500. 📌 The allocation continues to increase as the broader market falls further. The idea is simple: put more capital to work when the market becomes more distressed. 🔄 🎯 How I Pick Stoc
TransMedics Group, Inc., a commercial-stage medical technology company, engages in transforming organ transplant therapy for end-stage organ failure patients in the United States and internationally. The company offers Organ Care System (OCS), a portable organ perfusion, optimization, and monitoring system that utilizes its proprietary and customized technology to replicate near-physiologic conditions for donor organs outside of the human body. Its Organ Care System includes OCS LUNG for the preservation of standard criteria donor lungs for double-lung transplantation; OCS Heart, a technology for preservation of DBD donor hearts deemed unsuitable due to limitations of cold storage; and OCS Liver for the preservation of donor livers. The company was founded in 1998 and is headquartered in Andover, Massachusetts.